Literature DB >> 3026961

Leukotriene B4 induces enhanced migration of fish leucocytes in vitro.

T C Hunt, A F Rowley.   

Abstract

Leukotriene B4 (LTB4) was found to induce enhanced migration of the eosinophilic G1 granulocyte of the dogfish Scyliorhinus canicula in the migration under agarose assay. Higher levels of LTB4, however, were required to produce this effect than with mammalian neutrophils under similar conditions. It is postulated that this may be due to the dogfish granulocytes possessing fewer receptors for LTB4 than their mammalian counterparts. The eosinophilic G3 granulocyte was also tested using the same assay but results were inconclusive. The effect of LTB4 on dogfish G1 and G3 granulocytes was also monitored with the bipolar shape formation (BSF) assay. LTB4 induced BSF in both granulocyte types, and this method appeared to be more sensitive than the migration under agarose assay. Whether the enhanced migration observed is a result of chemotaxis or chemokinesis is not determined. This present study represents the first known report of the function of LTB4 in a non-mammalian vertebrate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026961      PMCID: PMC1453334     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  A modified method for chemotaxis under agarose.

Authors:  D E Chenoweth; J G Rowe; T E Hugli
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  Leukotriene B: a potential mediator of inflammation.

Authors:  M J Smith; A W Ford-Hutchinson; M A Bray
Journal:  J Pharm Pharmacol       Date:  1980-07       Impact factor: 3.765

3.  Quantitation of leukotaxis in agarose by three different methods.

Authors:  W Orr; P A Ward
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

4.  Preliminary studies on the chemotactic potential of dogfish (Scyliorhinus canicula) leucocytes using the bipolar shape formation assay.

Authors:  T C Hunt; A F Rowley
Journal:  Vet Immunol Immunopathol       Date:  1986-06       Impact factor: 2.046

5.  Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species.

Authors:  R M Palmer; R J Stepney; G A Higgs; K E Eakins
Journal:  Prostaglandins       Date:  1980-08

6.  Neutrophil bipolar shape formation in whole blood. A simple and rapid method for the assessment of neutrophil leukocyte responsiveness.

Authors:  D F Jadwin; C W Smith; T R Meadows
Journal:  Am J Clin Pathol       Date:  1981-10       Impact factor: 2.493

7.  Random and directed migration of trout (Salmo gairdneri) leukocytes: activation by antibody, complement, and normal serum components.

Authors:  B R Griffin
Journal:  Dev Comp Immunol       Date:  1984       Impact factor: 3.636

8.  Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes.

Authors:  J Grabbe; T Rosenbach; B M Czarnetzki
Journal:  J Invest Dermatol       Date:  1985-12       Impact factor: 8.551

9.  The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).

Authors:  E J Goetzl; W C Pickett
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  The release of leukotriene B4 during experimental inflammation.

Authors:  P M Simmons; J A Salmon; S Moncada
Journal:  Biochem Pharmacol       Date:  1983-04-15       Impact factor: 5.858

View more
  3 in total

1.  The effect of dietary vitamin A on the immunocompetence of Atlantic salmon (Salmo salar L.).

Authors:  I Thompson; T C Fletcher; D F Houlihan; C J Secombes
Journal:  Fish Physiol Biochem       Date:  1994-03       Impact factor: 2.794

2.  Acylation of lyso platelet-activating factor by splenocytes of the rainbow trout, Oncorhyncus mykiss.

Authors:  G L Pool; B Samples; M R Turner; R H Lumb
Journal:  Lipids       Date:  1991-07       Impact factor: 1.880

3.  The evolution of inflammatory mediators.

Authors:  A F Rowley
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.